| Product NDC: | 64679-945 |
| Proprietary Name: | ZONISAMIDE |
| Non Proprietary Name: | ZONISAMIDE |
| Active Ingredient(s): | 25 mg/1 & nbsp; ZONISAMIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 64679-945 |
| Labeler Name: | WOCKHARDT USA LLC. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077636 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060727 |
| Package NDC: | 64679-945-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (64679-945-01) |
| NDC Code | 64679-945-01 |
| Proprietary Name | ZONISAMIDE |
| Package Description | 100 CAPSULE in 1 BOTTLE (64679-945-01) |
| Product NDC | 64679-945 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ZONISAMIDE |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20060727 |
| Marketing Category Name | ANDA |
| Labeler Name | WOCKHARDT USA LLC. |
| Substance Name | ZONISAMIDE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |